XHKG
3883
Market cap26mUSD
Jul 10, Last price
0.04HKD
1D
-2.27%
1Q
-25.86%
Jan 2017
-97.58%
IPO
-99.42%
Name
China Aoyuan Group Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Aoyuan Group Limited, established in 1996 and headquartered in Guangzhou, People's Republic of China, operates as a diversified enterprise. A subsidiary of Ace Rise Profits Limited, the company's primary operations are segmented into Property Development, Property Investment, and various other ventures. Its core business involves the development and capital allocation for commercial real estate projects across Mainland China, Hong Kong, Australia, and Canada. Beyond this, China Aoyuan actively acquires and develops a broad spectrum of real estate endeavors, including the creation and management of cultural tourism, hospitality, sports, and resort facilities. The company also maintains a significant presence in international trade, facilitating the import and export of a wide array of consumer goods. This includes maternal and infant care products, cosmetics and skincare, apparel and accessories, food and beverages, household necessities, and parallel imported automobiles. Furthermore, China Aoyuan Group provides a comprehensive suite of services, encompassing a hybrid online and offline medical platform, consultancy expertise, construction services, and financial solutions. The company adopted its current name in November 2018, having previously operated as China Aoyuan Property Group Limited.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||